company background image
524470 logo

Syncom Formulations (India) BSE:524470 Stock Report

Last Price

₹19.51

Market Cap

₹18.3b

7D

-6.2%

1Y

56.5%

Updated

24 Nov, 2024

Data

Company Financials

Syncom Formulations (India) Limited

BSE:524470 Stock Report

Market Cap: ₹18.3b

524470 Stock Overview

Manufactures, markets, and sells pharmaceutical formulation products in India. More details

524470 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Syncom Formulations (India) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Syncom Formulations (India)
Historical stock prices
Current Share Price₹19.51
52 Week High₹27.94
52 Week Low₹10.60
Beta1.5
11 Month Change6.55%
3 Month Change-4.97%
1 Year Change56.46%
33 Year Change94.71%
5 Year Change2,279.27%
Change since IPO1,198.19%

Recent News & Updates

Recent updates

Shareholder Returns

524470IN PharmaceuticalsIN Market
7D-6.2%0.5%0.5%
1Y56.5%42.5%27.5%

Return vs Industry: 524470 exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.

Return vs Market: 524470 exceeded the Indian Market which returned 27.5% over the past year.

Price Volatility

Is 524470's price volatile compared to industry and market?
524470 volatility
524470 Average Weekly Movement9.5%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524470's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 524470's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1988998Vijay Bankdawww.syncomformulations.com

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations.

Syncom Formulations (India) Limited Fundamentals Summary

How do Syncom Formulations (India)'s earnings and revenue compare to its market cap?
524470 fundamental statistics
Market cap₹18.34b
Earnings (TTM)₹331.45m
Revenue (TTM)₹3.28b

55.3x

P/E Ratio

5.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524470 income statement (TTM)
Revenue₹3.28b
Cost of Revenue₹2.04b
Gross Profit₹1.25b
Other Expenses₹915.54m
Earnings₹331.45m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.35
Gross Margin37.98%
Net Profit Margin10.10%
Debt/Equity Ratio4.5%

How did 524470 perform over the long term?

See historical performance and comparison